by GlobeNewsWire | May 25, 2016 | Globe Newswire
IRVING, Texas, May 25, 2016 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (“Reata”), a clinical-stage biopharmaceutical company, today announced the pricing of its initial public offering of 5,500,000 shares of its Class A common stock at $11.00 per share,...
by GlobeNewsWire | May 25, 2016 | Globe Newswire
LA JOLLA, Calif., May 25, 2016 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), today announced that two abstracts detailing...
by GlobeNewsWire | May 25, 2016 | Globe Newswire
BILOXI, Miss., May 25, 2016 (GLOBE NEWSWIRE) — The United States Senate voted 55-43 today in support of Senate Resolution 28, which provides Congressional disapproval of a health and safety rule aimed to ensure the safety of American consumers. The Resolution...
by GlobeNewsWire | May 25, 2016 | Globe Newswire
NEW YORK, May 25, 2016 (GLOBE NEWSWIRE) — The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Ability, Inc. (“Ability” or “the Company”) (NASDAQ:ABIL) between...
by GlobeNewsWire | May 25, 2016 | Globe Newswire
NEW YORK, May 25, 2016 (GLOBE NEWSWIRE) — The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Ability, Inc. (“Ability” or “the Company”) (NASDAQ:ABIL) between...
